You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 11,273,131

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,273,131 protect, and when does it expire?

Patent 11,273,131 protects LIBERVANT and is included in one NDA.

This patent has twenty patent family members in eight countries.

Summary for Patent: 11,273,131

Title:	Pharmaceutical compositions with enhanced permeation
Abstract:	Pharmaceutical compositions having enhanced active component permeation properties are described.
Inventor(s):	Schobel Alexander Mark, Varjan Stephanie Marie, Wargacki Stephen Paul
Assignee:	AQUESTIVE THERAPEUTICS, INC.
Application Number:	US15724234
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 11,273,131

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-001	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-002	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-003	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-004	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,273,131

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	112018072467	⤷ Sign Up
Brazil	112020005967	⤷ Sign Up
Canada	3022797	⤷ Sign Up
Canada	3076815	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.